Q2i is a digital health company dedicated to developing, refining, validating, and commercializing innovative, evidence-based solutions.
Q2i’s technology is developed with
the support of, and in conjunction with:
Q2i’s academic partners include:
Q2i Research Projects
| Project Title | Date started | Status | Academic Partner/s |
| Buprenorphine induction low-dose to depot (build2depot): development of safe rapid transfer to depot medication and go/no go testing potential of remote community-based monitoring. | 2024 | In recruitment phase | |
| Prison release engagement trial, smartphone app to improve continuity of care post release for released prisoners (RPS) who want to stay drugfree | 2024 | In recruitment phase | |
| PARCA (a digital tool) to improve justice and health | 2023 | Phase I STTR successfully completed, and now in Phase II (Dallas and Austin) |   |
| Digital health technology improving successful community reintegration of recently released justice involved individuals with substance use disorders | 2020 | Phase I STTR successfully completed – results published |  |
| Reward-Based technology to improve opioid use disorder treatment after an ED visit | 2019 | Phase I and Phase II STTR successfully completed Completed – in data analysis phase | |
| Technology improving the success of medication assisted treatment in primary care | 2019 | Phase I and Phase II STTR successfully completed – Manuscript drafted ready for peer review | |
About Q2i
Our Mission
Our mission is to design, develop then supply the most advanced technologies that enable care teams to improve the success of their treatment programs and interventions.
Our Vision
Our vision is to drive innovation in order to increase the availability, accessibility, and success of treatment in a manner both convenient and effective.
About Q2i
Q2i, founded in 2016, is a software-as-a-service (SaaS) digital health company dedicated to addressing unmet technology needs in healthcare. By collaborating with multidisciplinary teams, providers, and payers, Q2i designs and develops innovative solutions to support organizations in achieving the IHI Quadruple Aim: enhancing the patient experience (including quality and satisfaction), improving population health, reducing per capita healthcare costs, and fostering a better experience for clinicians.